Transvenous versus subcutaneous implantable cardiac defibrillators for people at risk of sudden cardiac death-Reference-Cited by-同舟云学术

Transvenous versus subcutaneous implantable cardiac defibrillators for people at risk of sudden cardiac death

Published:2020-05-15 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Iskandarani Ghida¹,Khamis Assem M²,Sabra Mohammad³,Cai Minsi⁴,Akl Elie A³,Refaat Marwan³

Affiliation:

1. Faculty of Medicine; American University of Beirut Medical Center; Beirut Lebanon

2. Hull York Medical School; University of Hull; Hull UK

3. Department of Internal Medicine; American University of Beirut Medical Center; Beirut Lebanon

4. Department of Cardiac Arrythmia; Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College; Beijing China

Publisher

Wiley

Subject

Pharmacology (medical)

Reference61 articles.

1. Addressing dichotomous data for participants excluded from trial analysis: a guide for systematic reviewers;Akl;PloS one,2013

2. 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society;Al-Khatib;Journal of the American College of Cardiology,2018

3. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias;AVID Investigators;New England Journal of Medicine,1997

4. An entirely subcutaneous implantable cardioverter-defibrillator;Bardy;New England Journal of Medicine,2010

5. Subcutaneous versus transvenous implantable defibrillator therapy: a meta-analysis of case-control studies;Basu-Ray;Journal of the American College of Cardiology,2017